Luigi Meneghini, MD

Luigi Meneghini, MD, MBA

Endocrinology Dallas, TX

Professor, Department of Internal Medicine, University of Texas Southwestern Medical Center, Executive Director, Global Diabetes Program, Parkland Health & Hospital System

Office Address

  • 5323 Harry Hines Blvd
    Dallas, TX 75390
    Phone: (214) 648-3494

Luigi Meneghini, MD, MBA

Endocrinology Dallas, TX

Professor, Department of Internal Medicine, University of Texas Southwestern Medical Center, Executive Director, Global Diabetes Program, Parkland Health & Hospital System

Clinical Specialties & Interests

  • Endocrinology: Diabetes
  • Clinical Interests: Diabetes; Insulin management; Type 2 Diabetes Mellitus; Hypoglycemic Agents; Insulin; Blood Glucose; Type 1 Diabetes Mellitus; Glycosylated Hemoglobin A; Treatment Outcome; Long-Acting Insulin

Education & Medical Training

  • Emory University
  • Emory University School of MedicineEmory University School of Medicine
  • Jackson Memorial Hospital - Jackson Health SystemJackson Memorial Hospital - Jackson Health System
  • University of Miami
  • University of Miami School of Business

Certifications & Licensure

  • TX State Medical LicenseTX State Medical License2014 - 2016
  • FL State Medical LicenseFL State Medical License1990 - 2017
  • American Board of Internal MedicineInternal Medicine, 1991
  • American Board of Internal MedicineEndocrinology, Diabetes and Metabolism, 2014, Current

Awards, Honors, & Recognition

  • Who’s Who in AmericaMarquis, 2013-2014
  • The Leading Physicians of the WorldInternational Association of Healthcare Professionals, 2013-2014
  • Top Doctors:South FloridaCastle Connolly, 2012

Publications & Presentations


Journal Articles

  • Barriers to Initiating Insulin in Type 2 Diabetes Patients: Development of a New Patient Education Tool to Address Myths Misconceptions and Clinical Realities  Brod M, Alolga SL, Meneghini L, The Patient, 6/1/2014
  • SOLVE Study Group Safety of once-daily insulin detemir in patients with type 2 diabetes treated with oral hypoglycemic agents (OHAs) in routine clinical practice  Ross S, Dzida G, Ji Q, Kaiser M, Ligthelm R, Meneghini L, Nazeri A, Orozco-Beltran D, Pan C, Svendsen AL, J Diabetes, 5/1/2014
  • A patient-level analysis of efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine added to oral antidiabetes agents in people with ty...  DeVries H, Meneghini L, Barnett AH, Reid T, Dain MP, Landgraf W, Vlajnic A, Traylor L, Bergenstal RM, European Endocrinology, 1/1/2014

Books/Book Chapters

  • Type 1 Diabetes in Adults: Principles and Practice Chapter: Pathophysiology of Type 1 diabetes 
    Meneghini LF
    Editors: Jabbour & Stephens.Informa Healthcare USA, Inc, New York, NY


  • Lower within-subject variability in mean blood glucose concentration with insulin degludec vs. in-sulin glargine: a meta-analysis of patients with T2D Meneghini L, Harris S, Evans M, Rasmussen S, Johansen T, Pieber T, World Diabetes Congress, 12/1/2013
  • Reduced risk of hypoglycaemia with insulin degludec vs. insulin glargine in patients with type 2 diabetes and a BMI >30 kg/m2: a meta-analysis of five randomised tr... Philis-Tsimikas A, Rodbard HW, Meneghini LF, Kapur K, Endahl L, Russell-Jones DL, World Diabetes Congress, 12/1/2013
  • Reduced Risk of Hypoglycemia with Insulin Degludec vs. Insulin Glargine in Patients with Type 2 Diabetes and a BMI >30 kg/m(2): A Meta-analysis of 5 Randomized Trials Rodbard HW1, Meneghini LF, Russell-Jones DL, Kapur R, Endahl L, Kapor J, Philis-Tsimikas A, Can J Diabetes, 10/1/2013


  • Inpatient management of diabetes 12/1/2013
  • Ultra-Long Acting Basal Insulin Analogs: Challenges & Opportunities 11/1/2013
  • Advances in GLP1 Therapy: Current Agents and Combinations 11/1/2013


  • Update on the use of detemir insulin in the management of type 2 diabetes Meneghini LF, Sheik A, US Endocrinology
  • Managing Type 2 Diabetes in Ethnic Minority Populations Kahn K, Meneghini L, Clinical Medicine Today: Diabetes Newsletter
  • Current Treatment Options for a Type 2 Diabetes Patient Not Controlled on OADs Meneghini LF, Pri-Med Online

Other Languages

  • Spanish, French, Italian

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • AvMed Health Open Access
  • BCBS Blue Card PPO
  • BCBS California CaliforniaCare HMO
  • BCBS California PPO
  • BCBS Florida BlueCare HMO
  • BCBS Florida NetworkBlue
  • BCBS Florida Preferred Patient Care PPO
  • Blue Shield California HMO
  • Blue Shield California PPO
  • CIGNA Open Access
  • Coventry Florida - Employer Group HMO/Open Access
  • Coventry Florida - Employer Group PPO
  • First Health PPO
  • Great West PPO
  • Health Net California Large Group PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PHCS PPO - Kaiser
  • Multiplan PPO
  • Pacificare HMO
  • United - River Valley Neighborhood Health Partnership
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
  • WEA Trust Preferred Provider Plan - Trust Pref

Medical Groups

  • University of Miami Med Grp


  • The full profile is locked and available to verified physicians only.
    Join over 50% of U.S. physicians already on Doximity and get access to this and over 700,000 physician CVs. Find your physician profile

Physicians, view Dr. Meneghini's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV

© 2015 Doximity, Inc.GroupsHelpBlogCompanyContactPrivacyDirectory